On September 6, Sichuan Biokin Pharmaceutical Co., Ltd. (688506) issued a notice confirming its participation in the Star Market’s collective earnings briefing for the innovation drug sector covering the first half of 2026.
The virtual event is scheduled for September 16, 2026, from 15:00 to 17:00 Beijing time, providing a platform for the company to address queries and concerns raised by its investors.
This engagement underscores the firm’s commitment to transparent communication with the investment community regarding its semi-annual performance and strategic outlook.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments